Activeted-267406-2026
Framework Agreement on Pharmaceutical Rebates
Conclusion of rebate agreements for the active ingredient Adalimumab with pharmaceutical companies. Conditions are fixed and non-negotiable, with an accession option for unlimited partners.
CONTRACTING AUTHORITY
Name
Deutsche Rentenversicherung Knappschaft-Bahn-See
City
Bochum
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000 – Pharmaceutical products.
LOTS (8)
LOT-0001Supplies
Adalimumab (ATC-Code: L04AB04)
LOT-0002Supplies
Denosumab - 120 mg (ATC-Code: M05BX04)
LOT-0003Supplies
Denosumab - 60 mg (ATC-Code: M05BX04)
LOT-0004Supplies
Follitropin beta (ATC-Code: G03GA06)
LOT-0005Supplies
Golimumab (ATC-Code: L04AB06)
LOT-0006Supplies
Infliximab (ATC-Code: L04AB02)
LOT-0007Supplies
Lenograstim (ATC-Code: L03AA10)
LOT-0008Supplies
Ustekinumab (ATC-Code: L04AC05)
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
695 days remaining(LOT-0001)
Published